Cart (0 Items)
Your cart is currently empty.
View Products-
-
-
Dapirolizumab Biosimilar – Anti-CD40LG, CD154 mAb – Research Grade
| Size | 100ug, 1MG |
|---|---|
| Isotype | Fab'-G1-kappa |
| Brand | ProteoGenix |
| Product type | Primary Antibodies |
| Clonality | Monoclonal Antibody |
| Expression system | Mammalian cells |
| Applications | Elisa, WB |
| Product name | Dapirolizumab Biosimilar - Anti-CD40LG, CD154 mAb - Research Grade |
|---|---|
| Source | CAS 1416147-64-2 |
| Species | Humanized |
| Expression system | Mammalian cells |
| Purity | >85% |
| Buffer | PBS buffer PH7.5 |
| Delivery condition | Blue ice (+4°C) |
| Delivery Time | 3-5 days if in stock; 3-5 weeks if production needed |
| Storage condition | store at -80°C |
| Brand | ProteoGenix |
| Aliases /Synonyms | Dapirolizumab,CDP7657,CD40LG, CD154,anti-CD40LG, CD154 |
| Reference | PX-TA1337 |
| Note | For research use only. Not suitable for clinical or therapeutic use. |
| Isotype | Fab'-G1-kappa |
| Clonality | Monoclonal Antibody |
Description of Dapirolizumab Biosimilar - Anti-CD40LG, CD154 mAb - Research Grade
General information on Anti-CD40LG/CD154[Homo sapiens] (Dapirolizumab) Monoclonal Antibody
Dapirolizumab is investigated for the treatment of Systemic Lupus Erythematosus.
Related products
Antigen
CD40 ligand(CD40LG)
PX-P4855 182€Contact us
Got a question or need a quote?
Message us and we’ll get back to you 48 hours or less.
Reviews
There are no reviews yet.